We are live on ! Find out more
VIM

Vinva Investment Management Portfolio holdings

AUM $8.07B
1-Year Est. Return 29.46%
This Fund
S&P 500
This Quarter Est. Return
+13.57%
1 Year Est. Return
+29.46%
3 Year Est. Return
+116.68%
5 Year Est. Return
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$397M
Cap. Flow
+$247M
Cap. Flow %
16.8%
Top 10 Hldgs %
29.27%
Holding
417
New
62
Increased
255
Reduced
73
Closed
27

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$17.2M
2
AAPL icon
Apple
AAPL
+$14.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$12.9M
4
MSFT icon
Microsoft
MSFT
+$10.9M
5
NVDA icon
NVIDIA
NVDA
+$7.67M

Sector Composition

Rank Sector Weight
1 Technology 31.76%
2 Financials 14.39%
3 Healthcare 12.74%
4 Consumer Discretionary 12.55%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
51
Verizon
VZ
$196B
$6.58M 0.45%
175,399
+23,271
+15% +$823K
CVX icon
52
Chevron
CVX
$385B
$6.53M 0.44%
43,578
-2,299
-5% -$348K
CMCSA icon
53
Comcast
CMCSA
$90.3B
$6.44M 0.44%
146,064
+21,538
+17% +$923K
AMAT icon
54
Applied Materials
AMAT
$421B
$6.44M 0.44%
39,481
+13,748
+53% +$2.02M
FICO icon
55
Fair Isaac
FICO
$22.2B
$6.29M 0.43%
5,381
+1,896
+54% +$1.91M
WFC icon
56
Wells Fargo
WFC
$265B
$6.28M 0.43%
126,868
+18,952
+18% +$818K
UBER icon
57
Uber
UBER
$161B
$6.1M 0.42%
96,652
+24,841
+35% +$1.3M
TAP icon
58
Molson Coors Class B
TAP
$7.85B
$5.91M 0.4%
96,478
+46,101
+92% +$2.77M
BKNG icon
59
Booking.com
BKNG
$160B
$5.9M 0.4%
41,575
+13,900
+50% +$1.73M
INTC icon
60
Intel
INTC
$492B
$5.82M 0.4%
115,431
+55,478
+93% +$2.25M
MELI icon
61
Mercado Libre
MELI
$96.8B
$5.71M 0.39%
3,608
+903
+33% +$1.28M
GDDY icon
62
GoDaddy
GDDY
$11.6B
$5.67M 0.39%
+53,307
New +$4.77M
QCOM icon
63
Qualcomm
QCOM
$171B
$5.66M 0.39%
38,796
+6,367
+20% +$789K
DHR icon
64
Danaher
DHR
$145B
$5.54M 0.38%
23,773
+604
+3% +$129K
LEN icon
65
Lennar Class A
LEN
$20.8B
$5.42M 0.37%
37,529
-32,783
-47% -$3.95M
INTU icon
66
Intuit
INTU
$91.5B
$5.36M 0.36%
8,528
+258
+3% +$142K
SHW icon
67
Sherwin-Williams
SHW
$88.2B
$5.35M 0.36%
17,111
+3,903
+30% +$1.05M
AMGN icon
68
Amgen
AMGN
$224B
$5.32M 0.36%
18,459
+2,671
+17% +$728K
HLT icon
69
Hilton Worldwide
HLT
$70.4B
$5.29M 0.36%
29,110
+9,348
+47% +$1.53M
CAT icon
70
Caterpillar
CAT
$391B
$5.24M 0.36%
17,645
+3,472
+24% +$901K
SRE icon
71
Sempra
SRE
$55.2B
$5.22M 0.36%
69,890
+30,699
+78% +$2.2M
PLD icon
72
Prologis
PLD
$132B
$5.07M 0.35%
37,528
+9,127
+32% +$1.04M
LIN icon
73
Linde
LIN
$227B
$5.04M 0.34%
12,305
+9,029
+276% +$3.56M
SPGI icon
74
S&P Global
SPGI
$121B
$5M 0.34%
11,318
+2,219
+24% +$876K
CL icon
75
Colgate-Palmolive
CL
$73.6B
$5M 0.34%
63,092
+25,558
+68% +$1.92M

Similar funds

Vinva Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Vinva Investment Management held 417 positions worth $1.47B, up 37% from $1.07B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Vinva Investment Management deployed $247M of net new capital in Q4 2023, opening 62 new positions and adding to 255 existing holdings. Its largest new stake was UnitedHealth: 32,283 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Idexx Laboratories, an estimated $4.19M trimmed.

  • Vinva Investment Management's largest Q4 2023 buy was UnitedHealth: 32,283 shares worth $16.9M.
  • Vinva Investment Management added most to Apple in Q4 2023, an estimated $14.3M increase.
  • Vinva Investment Management's biggest Q4 2023 reduction was Idexx Laboratories, cutting an estimated $4.19M.
  • Vinva Investment Management fully exited Clorox in Q4 2023, selling an estimated $3.43M.
  • Vinva Investment Management's ten largest holdings make up 29% of its $1.47B portfolio in Q4 2023.
  • Vinva Investment Management opened 62 new positions and closed 27 in Q4 2023.
  • Vinva Investment Management's portfolio value rose 37% quarter-over-quarter to $1.47B.

Based on Vinva Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.